NEWS
- Featured Article: Harold Varmus Becomes Fourteenth Director of the National Cancer Institute
- Adherence Low among Women Taking Adjuvant Hormone Therapy for Early-stage Breast Cancer
- Drug that Inhibits DNA-repair Enzyme Shrinks Some Breast and Ovarian Tumors
- Colorectal Cancer Screening Rates Rise, Mammography Rates Dip Slightly in the U.S.
- Length of Telomeres Linked to Risk for Some Cancers
- Study Estimates Cancer Cases Due to Radiation Exposure in the Marshall Islands
IN DEPTH
- Synthetic Biology and Cancer: Exploring the Possibilities
- PSA Screening and Cancer Mortality: Swedish Study Adds to the Debate
- Featured Clinical Trial: Targeting HER2 in the Treatment of Ductal Carcinoma In Situ
- Cancer Survivors Discover the Power of Blogging
UPDATES
Give Us Feedback
Tell us what you think about the Bulletin or what you want to see in the Bulletin.
Cancer.gov Update
NCI Launches Comprehensive Biospecimen Resource Web Site
NCI’s Office of Biorepositories and Biospecimen Research has developed a new Web site to help advance the mission of its cancer Human Biobank (caHUB) initiative. The recently launched site hosts a variety of resources for the general public, professionals who work with biospecimens, potential partners, health care professionals, and patients. These include:
- Videos from thought leaders in the field of biospecimens
- Information about funding and partnership opportunities
- Reports for the scientific, policy, and advocacy communities
- Progress updates on this initiative to improve cancer research
caHUB was created in response to the critical shortage of high-quality, clinically annotated biospecimens, which are essential resources to accelerate the development of molecular-based diagnostics and therapeutics for personalized medicine. caHUB will contribute to medical advances by providing high-quality human specimens and data, as well as analyses, scientific tools, and services to the cancer research community and product development industries.
SEER Releases New U.S. Cancer Mortality Data
NCI’s Surveillance Research Program updated the 2010 SEER Cancer Statistics Review, 1975-2007 (CSR) to include U.S. cancer mortality data. This update is in addition to previously posted materials, which were released on April 15. Other materials available online include:
- SEER Data, 1973-2007
- Updated Stat Fact Sheets and Fast Stats
- Delay-Adjusted Incidence for SEER 9 and SEER 13
The updated CSR presents the most recent statistics on cancer incidence, survival, mortality, prevalence, and lifetime risk. All material in the SEER CSR report is in the public domain and may be reproduced or copied without permission. Citation of the original source is appreciated.
The latest SEER data were also released through SEER*Stat, statistical software that provides a mechanism for analyzing data in SEER and other cancer-related databases.
